
New Research Highlights Zabalafin Hydrogel's Novel Multi-Targeted Approach to AD Treatment
A recent paper published in the Journal of Drugs in Dermatology has highlighted Alphyn Biologics’ Zabalafin Hydrogel as a leading multi-target therapeutic for atopic dermatitis (AD).1 Although no single product is effective against all typical …